Advanced search
Publication Cover
Gynecological Endocrinology Volume 15, 2001 - Issue 5
Submit an article Journal homepage
37
Views
15
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone

J. H. J. M. Meuwissen Diagnostisch Centrum ,Eindhoven ,The Netherlands
,
L. Beijers-De Bie Diagnostisch Centrum ,Eindhoven ,The Netherlands
,
T. Vihtamaki Koskiklinikka ,Tampere ,Finland
,
R. Tuimala Koskiklinikka ,Tampere ,Finland
,
N. Siseles Hospital Frances-Carlos Calvo ,Buenos Aires ,Argentina
,
C. Magaril Hospital Ramos Mejia ,Buenos Aires ,Argentina
,
H. S. The St. Gemini Hospital ,Den Helder ,The Netherlands
,
P. W. H. Houben St. Gemini Hospital ,Den Helder ,The Netherlands
,
M. Murga Hospital Rivadavia ,Buenos Aires ,Argentina
,
D. Spielmann Wyeth-Ayerst ,Paris ,France
&
T. J. De Villiers Panorama Medi-Clinic ,Parow ,South Africa
 show all
Pages 349-358 | Published online: 28 Aug 2009

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Daniela Rouskova, Katrin Mittmann, Ulrike Schumacher, Horst Dietrich & Thomas Zimmermann. (2015) Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days. Gynecological Endocrinology 31:7, pages 560-564.
Read now
Regine Sitruk-Ware, Ronald Bossemeyer & Phillipe Bouchard. (2007) Preclinical and clinical properties of trimegestone: A potent and selective progestin. Gynecological Endocrinology 23:6, pages 310-319.
Read now
H Kuhl. (2005) Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 8:sup1, pages 3-63.
Read now
P. Bouchard, F. De Cicco-Nardone, D. Spielmann, N. Garcea & The Trimegestone 301 Study Group. (2005) Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women. Gynecological Endocrinology 21:3, pages 142-148.
Read now
R Sitruk-Ware, F Husmann, JHH Thijssen, SO Skouby, F Fruzzetti, J Hanker, J Huber & R Druckmann. (2004) Role of progestins with partial antiandrogenic effects. Climacteric 7:3, pages 238-254.
Read now

Articles from other publishers (10)

Petra Stute, Linus Josef Walker, Astrid Eicher, Elena Pavicic, Argyrios Kolokythas, Susanne Theis, Marc von Gernler, Michael von Wolff & Sabrina Vollrath. (2023) Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review. Best Practice & Research Clinical Endocrinology & Metabolism, pages 101815.
Crossref
S Iliodromiti, W Wang, MA Lumsden, MS Hunter, R Bell, G Mishra & M Hickey. (2019) Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology 127:3, pages 320-333.
Crossref
Susan Furness, Helen Roberts, Jane Marjoribanks & Anne Lethaby. (2012) Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database of Systematic Reviews.
Crossref
Susan Furness, Helen Roberts, Jane Marjoribanks, Anne Lethaby, Martha Hickey & Cindy Farquhar. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
May WahabFarook Al-Azzawi. (2016) Current State of Hormone Replacement Therapy: The Case for Using Trimegestone. Women's Health 2:4, pages 539-550.
Crossref
M. Birkhäuser. (2006) Klinische Bedeutung von gestagenen PartialwirkungenClinical significance of partial gestagen effects. Gynäkologische Endokrinologie 4:1, pages 52-64.
Crossref
Costantino Di Carlo, Annalidia Sammartino, Attilio Di Spiezio Sardo, Giovanni A Tommaselli, Maurizio Guida, Vincenzo D Mandato, Antonio D'Elia & Carmine Nappi. (2005) Bleeding patterns during continuous estradiol with different sequential progestogens therapy. Menopause 12:5, pages 520-525.
Crossref
. (2004) Vasomotor Symptoms. Obstetrics & Gynecology 104:Supplement 4, pages 16.
Crossref
Lise Warming, Pernille Ravn, Danièle Spielman, Pierre Delmas & Claus Christiansen. (2004) Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women. Menopause 11:3, pages 337-342.
Crossref
Michelle P Warren. (2004) A comparative review of the risks and benefits of hormone replacement therapy regimens. American Journal of Obstetrics and Gynecology 190:4, pages 1141-1167.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.